BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38553042)

  • 1. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
    Cotton CC; Eluri S; Shaheen NJ
    Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.
    Timmer MR; Martinez P; Lau CT; Westra WM; Calpe S; Rygiel AM; Rosmolen WD; Meijer SL; Ten Kate FJ; Dijkgraaf MG; Mallant-Hent RC; Naber AH; van Oijen AH; Baak LC; Scholten P; Böhmer CJ; Fockens P; Maley CC; Graham TA; Bergman JJ; Krishnadath KK
    Gut; 2016 Oct; 65(10):1602-10. PubMed ID: 26104750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's Esophagus and Associated Dysplasia.
    Patil DT; Odze RD
    Gastroenterol Clin North Am; 2024 Mar; 53(1):1-23. PubMed ID: 38280743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastro-oesophageal junction: a conceptual agreement at last?
    Genta RM
    Frontline Gastroenterol; 2023; 14(4):271-272. PubMed ID: 37409337
    [No Abstract]   [Full Text] [Related]  

  • 5. National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett's oesophagus and stage I oesophageal adenocarcinoma.
    di Pietro M; Trudgill NJ; Vasileiou M; Longcroft-Wheaton G; Phillips AW; Gossage J; Kaye PV; Foley KG; Crosby T; Nelson S; Griffiths H; Rahman M; Ritchie G; Crisp A; Deed S; Primrose JN
    Gut; 2024 May; 73(6):897-909. PubMed ID: 38553042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
    Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
    Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barrett's oesophagus surveillance: individual-level data analysis.
    Black EL; Ococks E; Devonshire G; Ng AWT; O'Donovan M; Malhotra S; Tripathi M; Miremadi A; Freeman A; Coles H; ; Fitzgerald RC
    Gut; 2024 Apr; 73(5):729-740. PubMed ID: 37989565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endoscopic resection in early-stage esophageal adenocarcinoma: Esophagectomy is associated with improved survival in patients presenting with clinical stage T1bN0 disease.
    Swanson J; Littau M; Tonelli C; Cohn T; Luchette FA; Abdelsattar Z; Baker MS
    Surgery; 2023 Mar; 173(3):693-701. PubMed ID: 36273971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's oesophagus with indefinite for dysplasia shows high rates of prevalent and incident neoplasia in a UK multicentre cohort.
    Kopczynska M; Ratcliffe E; Yalamanchili H; Thompson A; Nimri A; Britton J; Ang Y
    J Clin Pathol; 2023 Dec; 76(12):847-854. PubMed ID: 36150885
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.